Found 360 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
IL-15-Armored CAR-T Therapy in Relapsed or Refractory Multiple Myeloma and Plasma Cell Leukemia PHASE2 This is an open-label, single-arm, Phase 2 study to evaluate the efficacy a...
Show More Location
The First Hospital of Jilin University
Learn More & Join Trial
Dasatinib and Quercetin With CAR-T Therapy for the Treatment of Patients With Relapsed or Refractory Multiple Myeloma PHASE2 This phase II trial tests how well giving dasatinib and quercetin with cycl...
Show More Location
Mayo Clinic in Rochester
Learn More & Join Trial
A Study of a Fully Human BCMA-targeting CAR (CT103A) Combined With Selinexor in Patients With Relapsed/Refractory Extramedullary Multiple Myeloma PHASE1 This study is a single-center, open Phase I study, to observe the effective...
Show More Location
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Learn More & Join Trial
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease PHASE1 CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B cell mediated...
Show More Location
Children's Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
UTAA17 Injection in the Treatment of Relapsed/Refractory Multiple Myeloma NA The clinical trial was designed as a single-arm, open-label clinical study,...
Show More Location
The Second Affiliated Hospital of Soochow University
Learn More & Join Trial
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
A Study Comparing JNJ-68284528, a CAR-T Therapy Directed Against B-cell Maturation Antigen (BCMA), Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) or Daratumumab, Pomalidomide and Dexamethasone (DPd) in Participants With Relapsed and Lenalidomide-Refractory Multiple Myeloma PHASE3 The purpose of this study is to compare the efficacy of ciltacabtagene auto...
Show More Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Learn More & Join Trial
Comparing ASCT Followed by Anti-BCMA CAR-T vs. ASCT Alone in NDMM Patients Eligible for ASCT PHASE2 This is a prospective study comparing autologous hematopoietic stem cell tr...
Show More Location
The Affiliated Hospital oh Xuzhou Medical University
Learn More & Join Trial